The solubility-driven optimization of a series of 1,7-napthyridine phosphodiesterase-4 inhibitors is described. Directed structural changes resulted in increased aqueous solubility, enabling superior pharmacokinetic properties with retention of PDE4 inhibition. A range of potent and orally bioavailable compounds with good in vivo efficacy in animal models of inflammation and reduced emetic potential compared to previously described drugs were synthesized. Compound 2d was taken forward as a clinical candidate for the treatment of COPD.
Herein we describe the optimization of a series of PDE4 inhibitors, with special focus on solubility and pharamcokinetics, to clinical compound 2, 4-(8-(3-fluorophenyl)-1,7-naphthyridin-6-yl)transcyclohexanecarboxylic acid. Although compound 2 produces emesis in humans when given as a single dose, its exemplary pharmacokinetic properties enabled a novel dosing regime comprising multiple escalating doses and the resultant achievement of high plasma drug levels without associated nausea or emesis.
Rate constants for the reaction of a series of N-phenylnaphth-I -ylamines and some related nitroxides and hydroxylamines with t-alkylperoxyl radicals have been measured using kinetic e.s.r. spectrometry and activation energies and A factors have been derived. The stoicheiometry of the reaction (peroxyl radical to N-phenylnaphth-1 -ylamine) has been shown to be ca. 2 in all cases.Aromatic amines (AH) are used as antioxidants to protect organic materials against atmospheric They react with chain-propagating alkylperoxyl radicals (ROO.) by rapid intermolecular hydrogen exchange (i) to form a free radical (A*) which does not propagate the chain.
The syntheses are described of cyclo-{ [~-Trp*,Gaba'~]somatostatin-(5--12)-peptide)t (77), and (79)-(82) labelled singly at positions 6, 7, 8, and 11 and doubly at residues 6 and 11 to specific radioactivities of between 4.8 and 22.4 Ci mmol-'. The linear sequence (5-1 2) and the related cyclo-{ [~-Trp~,Nag'~]somatostatin-(5-1 2) -peptide} (78) and (83) were also prepared to specific radioactivities of 19.2 and 1 9.6 Ci mmol-' respectively. The syntheses of the labelled hexapeptide cyclo-{ [4-3H -Phe7,~-Trpe,Pro12]somatostatin-(7-1 2) -peptide} (84) and the full sequences [4-3H -Phes,D-Trp8,~-Cys14]somatostatin (94) and [~-Trp~,4-~H-Phe~',~-Cys'~]sornatostatin (95) labelled at ca. 13.0 Ci mmol-' are described. Labelling was effected by reductive dehalogenation in the presence of tritium of the fully protected precursors and the purity of the final products was assessed by amino acid analysis after acidic hydrolysis following purification by ion-exchange and h.p.1.c. as appropriate.
Die aus den Nitrosobenzol‐Derivaten (I) und den Naphthylmagnesiumbromiden (II) erhältlichen Hydroxylamine (III) werden bei der chromatographischen Reinigung zu den Nitroxiden (IV) oxidiert.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.